Michael J. Hennessy Associates, Inc. combines the power of heavyweight publishing capabilities with intimate, dedicated attention to the needs of our clients and audience. Whether or not you know our name, the chances are pretty good you’ve seen one or more of our brands. We fuse the key benefits of a major publisher and a full-service communications and media provider with the attention to detail and adaptability of a truly entrepreneurial enterprise.


    Through expert reporting, conference coverage, and our Peer Exchange® and Insights series, we offer medical research and breaking news to general physicians and specialty oncologists. Recently, we extended our services into the fields of dentistry and animal health.


    We are a full-service pharmacy media resource and a leader in the industry. Our portfolio includes digital, mobile, print, live events, and custom education offerings to deliver practical information and timely news that covers all facets of pharmacy, including the specialty space.


    Our leading peer-reviewed journals publish research that is critical to clinical and policy decision makers as they work to promote the efficient delivery of high-quality care. We collect stakeholder views from payers, providers, policymakers, and pharmaceutical leaders.


    Our patient portals inform and inspire patients, survivors, and caregivers through their health journey. We offer guidance for patients with cancer and the rare disease community, and support others through disease-specific information to help them understand their conditions.


    We partner with leading cancer centers, schools of nursing, oncology networks, and societies across the country to bring physicians, pharmacists, and patients the latest in research and practice improvement. Our exclusive partnerships offer unmatched insights.


OncLive® Selected 45 Fellows Nationwide For The National Fellows Forum On Gyn-Onc

  • 2018-04-24 15:09:00

OncLive®, the leading digital provider of resources and information to oncology professionals, announces the 45 selected winners to attend the National Fellows Forum: Gyn-Onc on April 26-28 in Miami, Florida. This program provides an opportunity to gynecologic oncology fellows to share their research and data with industry leaders and peers.

CURE® Magazine Names 2018 Extraordinary Healer® Award Finalists

  • 2018-04-23 06:07:00

CURE® magazine, the nation’s leading digital and print media enterprise focused on cancer patients, proudly announces Elizabeth Davis, RN, B.S.N., CPN, Jackie Miller, RN, B.S.N., OCN and Christine Stone, RN, M.S.N., OCN,as the three finalists for the 2018 Extraordinary Healer® Award for Oncology Nursing.

OncLive® to Host State of the Science Summit™ on Advanced Non-Small Cell Lung Cancer

  • 2018-04-23 06:07:00

OncLive®, the leading provider of resources and information to oncology professionals, will host the latest State of the Science Summit™ on advanced non-small cell lung cancer on April 26 at the Sheraton La Jolla Hotel in La Jolla, California. The event will be chaired by Lyudmila Bazhenova, M.D., medical oncologist, professor of medicine, University of California, San Diego Health.

Targeted Oncology™ To Launch Virtual Tumor Board

  • 2018-04-19 10:37:00

Targeted Oncology™, a print and digital resource that offers content and expert opinions on precision medicine in oncology, will launch the first Expert Perspective: Virtual Tumor Board on April 24. The Virtual Tumor Board is a video-editorial board discussion that features key opinion leaders from a specific oncological field. This first one will focus on chronic lymphocytic leukemia (CLL).

OncLive® to Focus on Hematologic Malignancies in Upcoming State of the Science Summit™

  • 2018-04-18 15:45:00

OncLive®, the leading digital provider of resources and information for oncology professionals, will presents its latest State of the Science Summit™ on hematologic malignancies on April 25 at Fairfield Inn and Suites by Marriott Charlotte Uptown in Charlotte, North Carolina. The event will be chaired by Saad Zafar Usmani, M.D., chief of Plasma Cell Disorders Program and Director of Clinical Research in Hematologic Malignancies, Atrium Health, Levine Cancer Institute.


2 Clarke Dr #100
Cranbury Township, NJ 08512

Phone: (609) 716-7777

Fax: (609) 716-9038